Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector

Experimental Hematology

Volumn 34, Issue 3, 2006, Pages 369-381

  Kahl, Christoph A ^a   Tarantal, Alice F ^b,c,d   Lee, Chang I ^b,d   Jimenez, Daniel F ^b,d   Choi, Christopher ^a   Pepper, Karen ^a   Petersen, Denise ^a   Fletcher, Misty D ^b,d   Leapley, Alyssa C ^b,d   Fisher, Jennifer ^b,d   Burns, Travis S ^b,d   Ultsch, Man Ni ^b,d   Dorey, Frederick J ^e   Kohn, Donald B ^a,e  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Pediatrics ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CD34 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; NEOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CD34 SELECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; GENETIC MARKER; HEMATOPOIETIC STEM CELL; LENTIVIRUS VECTOR; MALE; MARKER GENE; MYELOABLATIVE CONDITIONING; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; STEM CELL GENE THERAPY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; AREA UNDER CURVE; BASE SEQUENCE; BUSULFAN; CELL LINE; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC MARKERS; GENETIC VECTORS; HUMANS; LENTIVIRUS; MACACA MULATTA;

ANIMALIA; LENTIVIRUS; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 33644923202     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.12.005     Document Type: Article

References (36)

1. S. Hacein-Bey-Abina, C. Von Kalle, and M. Schmidt LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419
2. M. Cavazzano-Calvo, S. Hacein-Bey, and G. de Saint Basile Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672
3. L. Naldini, U. Bloemer, and P. Gallay In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 272 1996 263 267
4. H. Miyoshi, K.A. Smith, D.E. Mosier, I.M. Verma, and B.E. Torbett Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors Science 283 1999 682 686
5. U.S. Schuler, U.D. Renner, and F. Kroschinsky Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation Br J Haematol 114 2001 944 950
6. M. Mardiney, and H.L. Malech Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy Blood 87 1996 4049 4056
7. R.D. Huhn, J.F. Tisdale, B. Agricola, M.E. Metzger, R.E. Donahue, and C.E. Dunbar Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning Hum Gene Ther 10 1999 1783 1790
8. M. Rosenzweig, T.J. MacVittie, and D. Harper Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning Blood 94 1999 2271 2286
9. R. van Os, D. Dawes, J.M.K. Mislow, A. Witsell, and P.M. Mauch Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment Blood 89 1997 2376 2383
10. A. Aiuti, S. Slavin, and M. Aker Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning Science 296 2002 2410 2413
11. P.-E. Mangeot, D. Nègre, and B. Dubois Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells J Virol 74 2000 8307 8315
12. D. Nègre, P.-E. Mangeot, and G. Duisit Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells Gene Ther 7 2000 1613 1623
13. Y. Hanazono, K.E. Brown, and A. Handa In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectors Blood 94 1999 2263 2270
14. D.L. Haas, S.S. Case, G.M. Crooks, and D.B. Kohn Critical factors influencing stable transduction of human CD34+ cells with HIV-1-derived lentiviral vectors Mol Ther 2 2000 71 80
15. Y. Soneoka, P.M. Cannon, and E.E. Ramsdale A transient three-plasmid expression system for the production of high titer retroviral vectors Nucleic Acids Res 23 1995 628 633
16. M.A. Price, S.S. Case, and D.A. Carbonaro Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells Mol Ther 6 2002 645 652
17. C.A. Heid, J. Stevens, K.J. Livak, and P.M. Williams Real time quantitative PCR Genome Res 6 1996 986 994
18. A.D. Miller, and G.J. Rosman Improved retroviral vectors for gene transfer and expression Biotechniques 7 1989 980 990
19. A.F. Tarantal, and A.G. Hendrickx Prenatal growth in the cynomolgus and rhesus macaque (Macaca fascicularis and Macaca mulatta) - a comparison by ultrasonography Am J Primatol 15 1988 309 323
20. A.F. Tarantal, O. Goldstein, F. Barley, and M.J. Cowan Transplantation of human peripheral blood stem cells into fetal rhesus monkeys (Macaca mulatta) Transplantation 69 2000 1818 1823
21. D.F. Jimenez, A.C. Leapley, C.L. Lee, M.-N. Ultsch, and A.F. Tarantal Fetal CD34+ cells in the maternal circulation and long-term microchimerism in rhesus monkeys (Macaca mulatta) Transplantation 79 2005 142 146
22. D. DuBois, and E. DuBois A formula to estimate the approximate surface area if height and weight be known Arch Intern Med 17 1916 863 871
23. J.T. Slattery, J.E. Sanders, and C.D. Buckner Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics Bone Marrow Transplant 16 1995 31 42
24. D.F. Jimenez, and A.F. Tarantal Quantitative analysis of male fetal DNA in maternal serum of gravid rhesus monkeys (Macaca mulatta) Pediatr Res 53 2003 18 23
25. Y.M. Lo, M.S. Tein, and T.K. Lau Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis Am J Hum Genet 62 1998 768 775
26. M. Hassan, P. Ljungman, and P. Bolme Busulfan bioavailability Blood 84 1994 2144 2150
27. A.M. Yeager, J.E. Wagner JR., M.L. Graham, R.J. Jones, G.W. Santos, and L.B. Grochow Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation Blood 80 1992 2425 2428
28. G. Vassal, A. Deroussent, and D. Challine Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 79 1992 2475 2479
29. V. Sandrin, B. Boson, and P. Salmon Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates Blood 100 2002 823 832
30. J.D. Down, A. Boudewijn, J.H. Dillingh, B.W. Fox, and R.E. Ploemacher Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs Br J Cancer 70 1994 611 616
31. J.D. Down, and R.E. Ploemacher Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs Exp Hematol 21 1993 913 921
32. J.T. Slattery, and L.J. Risler Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation Ther Drug Monit 20 1998 543 549
33. S.S. Rao, S.O. Peters, R.B. Crittenden, F.M. Stewart, H.S. Ramshaw, and P.J. Quesenberry Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment Exp Hematol 25 1997 114 121
34. M. Stremlau, C.M. Owens, M.J. Perron, M. Kiessling, P. Autissier, and J. Sodroski The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys Nature 427 2004 848 853
35. S.S. Case, M.A. Price, and C.T. Jordan Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors Proc Natl Acad Sci U S A 96 1999 2988 2993
36. H. Hanawa, P. Hematti, and K. Keyvanfar Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system Blood 103 2004 4062 4069